TrialAntimicrobial agents and chemotherapy2024

First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults.

Vinay Kumar Venishetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.